Tag results:
Publication
ESC & iPSC News
Lineage Regulators TFAP2C and NR5A2 Function as Bipotency Activators in Totipotent Embryos
[Nature Structural & Molecular Biology] Researchers investigated the transcription factors regulomes during the first lineage specification in early mouse embryos, spanning the pre-initiation, initiation, commitment, and maintenance phases.
Immune Regulation News
Bispecific Dendritic-T Cell Engager Potentiates Anti-Tumor Immunity
[Cell] Scientists developed a bispecific DC-T cell engager, a reagent that facilitated physical interactions between PD-1+ T cells and conventional type I dendritic cells.
Immune Regulation News
Macrophages Reprogramming Improves Immunotherapy of IL-33 in Peritoneal Metastasis of Gastric Cancer
[EMBO Molecular Medicine] In immunocompetent mice, intraperitoneal administration of IL-33 could induce a celiac inflammatory environment, activated immunologic effector cells, and reverse the immunosuppressive tumor microenvironment, which effectively delayed tumor progression and peritoneal metastasis of gastric cancer.
Immune Regulation News
Illuminating T Cell-Dendritic Cell Interactions In Vivo by FlAsHing Antigens
[eLife] Scientists developed a novel and versatile immune monitoring strategy by adding a short cysteine-rich tag to antigenic peptides that emited fluorescence upon binding to thiol-reactive biarsenical hairpin compounds.
Human Immunology News
Non-Apoptotic FAS Signaling Controls mTOR Activation and Extrafollicular Maturation in Human B Cells
[Science Immunology] Modeling initial T-dependent B cell activation with CD40L en vitro, researchers showed that FAS competent cells with transient FAS ligation showed specifically decreased mTOR axis activation without apoptosis.
Human Immunology News
Tumor Resistance to Anti-Mesothelin CAR-T Cells Caused by Binding to Shed Mesothelin Is Overcome by Targeting a Juxtamembrane Epitope
[Proceedings Of The National Academy Of Sciences Of The United States Of America] Scientists developed an antibody (15B6) that bound next to the membrane at the protease-sensitive region, did not bind to shed mesothelin, and made CAR-T cells that had much higher anti-tumor activity than a CAR-T that binds to shed mesothelin.